[BREAKING] [Comprehensive] [Features] Kainosmed's lower limit due to refusal to approve Phase II of Parkinson's disease.

1 April Share

[BREAKING] [Comprehensive] [Features] Kainosmed's lower limit due to refusal to approve Phase II of Parkinson's disease.

【総合】【特徴】カイノスメッド，パーキンソン病臨床2相承認拒絶で下限価

[综合] 凯诺斯美德，帕金森氏病临床2奖因拒绝承认而下限

[Объединяет ли это с отказом утвердить клиническое подтверждение болезни Паркинсона?]

[종합] [특징]카이노스메드, 파킨슨병 임상2상 승인 거절로 하한가 [More News]